These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1770270)

  • 61. Luteal phase defects in assisted reproduction: the role of luteal phase supplementation.
    Capitanio GL; Ubaldi F; Giannini P; Croce S
    Acta Eur Fertil; 1992; 23(1):15-9. PubMed ID: 1293894
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effects of metoclopramide-induced hyperprolactinemia during early follicular development on human ovarian function.
    Kauppila A; Kirkinen P; Orava M; Vihko R
    J Clin Endocrinol Metab; 1984 Nov; 59(5):875-81. PubMed ID: 6384260
    [TBL] [Abstract][Full Text] [Related]  

  • 63. One ovary or two: differences in ovulation induction, estradiol levels, and follicular development in a program for in vitro fertilization.
    Diamond MP; Wentz AC; Herbert CM; Pittaway DE; Maxson WS; Daniell JF
    Fertil Steril; 1984 Apr; 41(4):524-9. PubMed ID: 6423412
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Luteal phase hyperprolactinemia.
    Falk RJ; Anderson L
    Int J Fertil Menopausal Stud; 1994; 39(5):272-7. PubMed ID: 7820160
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Comparing the clinical utility of GnRH antagonist to GnRH agonist in an oocyte donation program.
    Sauer MV; Paulson RJ; Lobo RA
    Gynecol Obstet Invest; 1997; 43(4):215-8. PubMed ID: 9194617
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Use of GnRH analog for induction of the ovulatory surge of gonadotropins in patients at risk of the ovarian hyperstimulation syndrome.
    Kulikowski M; Wołczyński S; Kuczyński W; Grochowski D; Szamatowicz M
    Gynecol Endocrinol; 1995 Jun; 9(2):97-102. PubMed ID: 7502696
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Endogenous luteinizing hormone surge during superovulation induction with sequential use of clomiphene citrate and pulsatile human menopausal gonadotropin.
    Messinis IE; Templeton A; Baird DT
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1076-80. PubMed ID: 3932447
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Midcycle administration of single-dose GnRHa for luteal phase failure in women with ovarian hyperstimulation. A report of five cases.
    Wu TC
    J Reprod Med; 2000 Feb; 45(2):156-8. PubMed ID: 10710751
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Subcutaneous low dose leuprolide acetate depot versus leuprolide acetate for women undergoing ovarian stimulation for in-vitro fertilization.
    Tsai HD; Chen CM; Lo HY; Chang CC
    Hum Reprod; 1995 Nov; 10(11):2909-12. PubMed ID: 8747042
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Efficiency and cost effectiveness of three protocols for gamete transfer.
    Awadalla SG; Randall GW
    J In Vitro Fert Embryo Transf; 1991 Dec; 8(6):344-8. PubMed ID: 1770276
    [No Abstract]   [Full Text] [Related]  

  • 71. Luteal phase after ovarian hyperstimulation.
    Messinis IE; Templeton A; Baird DT
    Br J Obstet Gynaecol; 1987 Apr; 94(4):345-50. PubMed ID: 3107612
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Different hormonal patterns in human menopausal gonadotropin-treated, clomiphene citrate-treated, and untreated conception cycles.
    Bohnet HG; Kato K; Trapp M; Weise HC; Leidenberger FA
    Fertil Steril; 1986 Apr; 45(4):469-74. PubMed ID: 2937655
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Plasma gastrointestinal hormones during spontaneous and induced menstrual cycles.
    Holst N; Jenssen TG; Burhol PG; Haug E; Forsdahl F
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1160-6. PubMed ID: 2498386
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Analysis of therapeutic outcomes of polycystic ovary syndrome patients with hyperprolactinemia].
    Shi YH; Sheng Y; Chen ZJ; Yan JH; Gao Q; Liu H; Ma ZX
    Zhonghua Fu Chan Ke Za Zhi; 2008 Apr; 43(4):251-3. PubMed ID: 18843962
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Endocrine responses to gonadotrophins after LHRH agonist administration on cycle days 1-4: prevention of premature luteinization.
    Martikainen H; Rönnberg L; Tapanainen J; Puistola U; Orava M; Kauppila A
    Hum Reprod; 1990 Apr; 5(3):246-9. PubMed ID: 2112552
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The luteal phase after ovarian stimulation.
    Kolibianakis EM; Devroey P
    Reprod Biomed Online; 2002; 5 Suppl 1():26-35. PubMed ID: 12537779
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A comparison of clomiphene/menotropins and D-Trp6-LH-RH/menotropins cycles of IVF-ET in the same patients.
    Ron-El R; Caspi E; Golan A; Nachum H; Herman A; Soffer Y; Weinraub Z
    Int J Fertil; 1991; 36(3):157-61. PubMed ID: 1678370
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clomiphene citrate and ovulation induction.
    Sovino H; Sir-Petermann T; Devoto L
    Reprod Biomed Online; 2002; 4(3):303-10. PubMed ID: 12709286
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A controlled study of luteinizing hormone-releasing hormone agonist (buserelin) for the induction of folliculogenesis before in vitro fertilization.
    MacLachlan V; Besanko M; O'Shea F; Wade H; Wood C; Trounson A; Healy DL
    N Engl J Med; 1989 May; 320(19):1233-7. PubMed ID: 2496310
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Levels of steroid and protein hormones in antral fluids of women treated with different combinations of gonadotropins, clomiphene citrate, and a gonadotropin-releasing hormone analog.
    Stone BA; Vargyas JM; Marrs RP; Quinn PJ; Batzofin JH; Tan T; Kerin JF; Serafini PC
    Fertil Steril; 1988 Feb; 49(2):249-57. PubMed ID: 3123276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.